ONL Therapeutics: Raises $46.9M in Series B Financing
ONL Therapeutics, Inc., an Ann Arbor, Mich.-based biopharmaceutical company, closed on $46.9m in a Series B financing round
This funding supports the completion...
© 2026 FintechInshorts. All Rights Reserved.

